Active Funding Opportunities and Notices for NICHD
NICHD publishes and participates in various notices of funding opportunities (NOFOs) and NIH Guide Notices (NOTs) to support research and training activities.
NOTs and Active NOFOs for NICHD
Please note: the following are sorted by date, from most recent to older. Select a table heading to change how to sort the information.
| Number Sort ascending | Exp. Date | Activity Code(s) | Title |
|---|---|---|---|
| RFA-HD-25-004 | July 31, 2024 | U19 | Optimizing Health of Children and Adolescents with Perinatal HIV Exposure (U19 Clinical Trial Optional) |
| RFA-HD-25-001 | July 31, 2024 | P50 | Medical Rehabilitation Research Resource (P50 Clinical Trial Optional) |
| RFA-EY-23-001 | June 16, 2026 | R21 | BRAIN Initiative: New Concepts and Early-Stage Research for Recording and Modulation in the Nervous System (R21) (Clinical Trial Not Allowed) |
| RFA-EB-22-002 | June 18, 2025 | R18 | HEAL Initiative: Translational Development of Diagnostic and Therapeutic Devices (R18 Clinical Trial Not Allowed) |
| RFA-DC-24-001 | September 20, 2025 | R61 | BRAIN Initiative: Exploratory Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain (R61 Basic Experimental Studies with Humans Required) |
| RFA-DA-23-039 | September 13, 2024 | R01 | BRAIN Initiative: Theories, Models and Methods for Analysis of Complex Data from the Brain (R01 Clinical Trial Not Allowed) |
| RFA-AI-24-018 | July 31, 2024 | R01 | Interaction between ARVs and Hormones in HIV and Coinfections (R01 Clinical Trial Optional) |
| RFA-AG-25-002 | July 3, 2024 | U54 | Consortium for Palliative Care Research Across the Lifespan (U54 Clinical Trial Optional) |
| PAR-24-206 | August 14, 2024 | U54 | Rare Diseases Clinical Research Consortia (RDCRC) for the Rare Diseases Clinical Research Network (RDCRN) (U54 Clinical Trial Optional) |
| PAR-24-197 | July 17, 2026 | R03 | HEAL Initiative-Early-Stage Discovery of New Pain Targets Within the Understudied Druggable Proteome (R03 Clinical Trial Not Allowed) |
| PAR-24-161 | May 8, 2027 | R21 | New Approaches for Measuring Brain Changes Across Longer Timespans (R21 Clinical Trial Optional) |
| PAR-24-160 | May 8, 2027 | R01 | New Approaches for Measuring Brain Changes Across Longer Timespans (R01 Clinical Trial Optional) |
| PAR-24-145 | January 8, 2027 | R16 | Support for Research Excellence First Independent Research (SuRE-First) Award (R16 - Clinical Trial Not Allowed) |
| PAR-24-144 | January 8, 2027 | R16 | Support for Research Excellence (SuRE) Award (R16 Clinical Trial Not Allowed) |
| PAR-24-134 | April 6, 2027 | R41/R42 | Small Business Transition Grant for New Entrepreneurs (R41/R42 Clinical Trial Required) |
| PAR-24-133 | April 6, 2027 | R41/R42 | Small Business Transition Grant for New Entrepreneurs (R41/R42 Clinical Trial Not Allowed) |
| PAR-24-132 | April 6, 2027 | R43/R44 | Small Business Transition Grant for New Entrepreneurs (R43/R44 Clinical Trial Required) |
| PAR-24-131 | April 6, 2027 | R43/R44 | Small Business Transition Grant for New Entrepreneurs (R43/R44 Clinical Trial Not Allowed) |
| PAR-24-081 | March 14, 2026 | X01 | Omics Phenotypes Related to Down Syndrome for the INCLUDE Project (X01 Clinical Trial Not Allowed) |
| PAR-24-077 | January 8, 2027 | R01 | Addressing Health and Health Care Disparities among Sexual and Gender Minority Populations (R01 - Clinical Trials Optional) |
BACK TO TOP